Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
530125 On Other Exchanges
Symbol
Exchange
530125 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

samrat pharmachem ltd (530125) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SAMRAT PHARMACHEM LTD (530125)

Related News

No related news articles were found.

samrat pharmachem ltd (530125) Related Businessweek News

No Related Businessweek News Found

samrat pharmachem ltd (530125) Details

Samrat Pharmachem Limited produces and sells pharmaceutical chemicals in India. The company primarily sells iodine and bromine salts. Its products include calcium iodate monohydrate, copper iodide, hydriodic acid, iodine, iodine monochloride, iodoethane, iodomethane, potassium bromide, potassium iodate, potassium iodide, potassium metaperiodate, sodium iodate, sodium iodide, sodium metaperiodate, and trimethyl sulfoxoniumiodide. The company’s finished products are primarily used in various industries, including pharmaceuticals, chemicals, food, fertilizer, salt, etc. Samrat Pharmachem Limited also exports its products. The company was incorporated in 1992 and is based in Mumbai, India.

29 Employees
Last Reported Date: 09/3/15

samrat pharmachem ltd (530125) Top Compensated Officers

Chairman, Chief Executive Officer and Managin...
Total Annual Compensation: 1.5M
Executive Director of Finance, Executive Dire...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2015.

samrat pharmachem ltd (530125) Key Developments

Samrat Pharmachem Ltd, Board Meeting, Feb 13, 2016

Samrat Pharmachem Ltd, Board Meeting, Feb 13, 2016. Agenda: To consider quarterly results.

Samrat Pharmachem Ltd expected to report Q3 2016 results on February 13, 2016. This event was calculated by Capital IQ (Created on November 22, 2015).

Samrat Pharmachem Ltd expected to report Q3 2016 results on February 13, 2016. This event was calculated by Capital IQ (Created on November 22, 2015).

Samrat Pharmachem Ltd. Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2015

Samrat Pharmachem Ltd. announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported that net income from sales/services was INR 127.74 million against INR 150.868 million a year ago. Profit from operations before other income, interest & exceptional items was INR 1.238 million against INR 3.974 million a year ago. Profit from ordinary activities before tax was INR 0.485 million against INR 2.054 million a year ago. Net profit was INR 0.434 million or INR 0.14 per basic and diluted share before and after extraordinary items against INR 1.422 million or INR 0.46 per basic and diluted share before and after extraordinary items a year ago. For the six months, the company reported that net income from sales/services was INR 253.393 million against INR 292.249 million a year ago. Profit from operations before other income, interest & exceptional items was INR 2.739 million against INR 8.938 million a year ago. Profit from ordinary activities before tax was INR 1.683 million against INR 6.093 million a year ago. Net profit was INR 1.15 million or INR 0.37 per basic and diluted share before and after extraordinary items against INR 3.813 million or INR 1.23 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SMPM:IN 26.15 INR 0.00

530125 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 530125.
View Industry Companies
 

Industry Analysis

530125

Industry Average

Valuation 530125 Industry Range
Price/Earnings 100.0x
Price/Sales 0.2x
Price/Book 0.6x
Price/Cash Flow 16.2x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SAMRAT PHARMACHEM LTD, please visit www.samratpharmachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.